![]() |
When Is a Headache a Migraine?
|
![]() |
Pharmacological Approaches to Preventing and Treating Migraine Attacks
|
![]() |
Living with Migraine
|
![]() |
What Are the Different Types of Headaches?
|
![]() |
Non-Pharmacological Approaches to Migraine Prevention
|
![]() |
Talking to Your Doctor About Migraines
|
Migraine is diagnosed by a careful medical history. Lab tests and imaging studies such as computed tomography (CT scan) or magnetic resonance imaging (MRI) scans have not been useful for identifying migraine. However, for some patients, those tests may be needed to rule out a brain tumor or other structural causes of migraine headache.
Once a migraine begins, the person will usually seek out a dark, quiet room to lessen painful stimuli. Several drugs may be used to reduce the pain and severity of the attack.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are helpful for early and mild headache. NSAIDs include acetaminophen, ibuprofen, naproxen, and others. A recent study concluded that a combination of acetaminophen, aspirin, and caffeine could effectively relieve symptoms for many migraine patients. One such over-the-counter preparation is available as Exedrin Migraine.
More severe or unresponsive attacks may be treated with drugs that act on serotonin receptors in the smooth muscle surrounding cranial blood vessels. Serotonin, also known as 5-hydroxytryptamine, constricts these vessels, relieving migraine pain. Drugs that mimic serotonin and bind to these receptors have the same effect. The oldest of them is ergotamine, a derivative of a common grain fungus. Ergotamine and dihydroergotamine are used for both acute and preventive treatment. Derivatives with fewer side effects have come onto the market in the past decade, including sumatriptan (Imitrex). Some of these drugs are available as nasal sprays, intramuscular injections, or rectal suppositories for patients in whom vomiting precludes oral administration. Other drugs used for acute attacks include meperidine and metoclopramide.
Studies are showing that rizatriptan is a promising drug for the treatment of migraines. One study showed that 10mg of rizatriptan provided relief to 90% of the patients in the study group and kept 50% of them pain-free 2 hours after taking the medication. Sumatriptan has been on the market since 1993, while rizatriptan became available in 1998.
Continued use of some anti-migraine drugs can lead to "rebound headache," marked by frequent or chronic headaches, especially in the early morning hours. Rebound headache is avoided by using anti-migraine drugs under a doctor's supervision, with the minimum dose necessary to treat symptoms. Patients with frequent migraines may need preventive therapy.
Alternative treatments are aimed at prevention of migraine. Migraine headaches are often linked with food
Most people with migraines can bring their attacks under control through recognizing and avoiding triggers, and by use of appropriate drugs when migraine occurs. Some people with severe migraines do not respond to preventive or drug therapy. Migraines usually wane in intensity by age 60 and beyond.
The frequency of migraine may be lessened by avoiding triggers. It is useful to keep a headache journal, recording the particulars and noting possible triggers for each attack. Specific measures which may help include:
Some drugs can be used for migraine prevention, including specific members of these drug classes:
For most patients, preventive drug therapy is not an appropriate option, since it requires continued use of powerful drugs. However, for women whose migraines coincide with the menstrual period, limited preventive treatment may be effective. Since these drugs are appropriate for patients with other medical conditions, the decision to prescribe them for migraine may be influenced by expected benefit elsewhere.
Larson, David E. Mayo Clinic Family Health Book. New York:
William Morrow and Company, 1996.
Rakel, Robert. Conn's Current Therapy: Latest Approved Methods of Treatment for the Practicing Physician. Philadelphia: W.B. Saunders Company, 2001.
Tierney, Lawrence, et. al. Current Medical Diagnosis and Treatment. Los Altos: Lange Medical Publications, 2001.
|
|
Author Info: Kim A. Sharp MLn, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Medicine, 2002 |